Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Thyroid

Retrieve available abstracts of 258 articles:
HTML format



Single Articles


    November 2022
  1. THIESMEYER JW, Egan C, Greenberg JA, Beninato T, et al
    Prepubertal Children with Papillary Thyroid Carcinoma Present with More Invasive Disease than Adolescents and Young Adults.
    Thyroid. 2022 Nov 10. doi: 10.1089/thy.2022.0098.
    PubMed     Abstract available


  2. LINKS MH, Lefrandt JD, Lisman T, van der Boom T, et al
    Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study.
    Thyroid. 2022 Nov 2. doi: 10.1089/thy.2022.0299.
    PubMed     Abstract available


  3. TANEJA C, Yip L, Morariu EM, Seethala R, et al
    Clinicopathologic Characteristics and Postsurgical Follow-Up of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in the Postnomenclature Revision Era.
    Thyroid. 2022;32:1346-1352.
    PubMed     Abstract available


    October 2022
  4. DUVAL MADS, Ferreira CV, Marmitt L, Dora JM, et al
    An undetectable postoperative calcitonin level is associated with long-term disease-free survival in medullary thyroid carcinoma: Results of a retrospective cohort study.
    Thyroid. 2022 Oct 12. doi: 10.1089/thy.2022.0295.
    PubMed     Abstract available


  5. SASAKI T, Miyauchi A, Fujishima M, Ito Y, et al
    Comparison of postoperative unfavorable events in patients with low-risk papillary thyroid carcinoma: Immediate surgery vs. conversion surgery following active surveillance.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0444.
    PubMed     Abstract available


  6. HO AS, Bastien AJ, Sacks W
    Thyroid Cancer Active Surveillance: The Devil You Know Or The Devil You Don't.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2022.0541.
    PubMed     Abstract available


  7. LEE EK, Moon JH, Hwangbo Y, Ryu CH, et al
    Progression of Low-risk Papillary Thyroid Microcarcinoma During Active Surveillance: Interim analysis of a Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro) in Korea.
    Thyroid. 2022 Oct 7. doi: 10.1089/thy.2021.0614.
    PubMed     Abstract available


    September 2022
  8. TUTTLE RM MD, Fagin JA, Minkowitz G, Wong RJ, et al
    Active surveillance of papillary thyroid cancer-frequency and time course of the 6 most common tumor volume kinetic patterns.
    Thyroid. 2022 Sep 30. doi: 10.1089/thy.2022.0325.
    PubMed     Abstract available


  9. GUILMETTE J, Dias-Santagata D, Lennerz JK, Selig MK, et al
    Primary Thyroid Neoplasm with Fetal Morphology Associated with DICER1 Mutations: Expanding the Diagnostic Profile of Thyroblastoma.
    Thyroid. 2022 Sep 30. doi: 10.1089/thy.2022.0060.
    PubMed     Abstract available


  10. HE Q, Cao H, Zhao Y, Chen P, et al
    DPP4 stabilizes integrin alpha4beta1 complex to promote thyroid cancer cell metastasis by activating TGF-beta signaling pathway.
    Thyroid. 2022 Sep 27. doi: 10.1089/thy.2022.0317.
    PubMed     Abstract available


  11. LEE H, Krishnan V, Wirth LJ, Nucera C, et al
    Case Report of CCDC149-ALK fusion: a novel genetic alteration and a clinically relevant target in metastatic papillary thyroid carcinoma.
    Thyroid. 2022 Sep 23. doi: 10.1089/thy.2022.0389.
    PubMed     Abstract available


  12. HALADA S, Baran J, Bauer AJ, Ricarte-Filho JC, et al
    Clinicopathologic Characteristics of Pediatric Follicular Variant of Papillary Thyroid Carcinoma Subtypes: A Retrospective Cohort Study.
    Thyroid. 2022 Sep 14. doi: 10.1089/thy.2022.0239.
    PubMed     Abstract available


  13. GRANI G, Lamartina L, Montesano T, Giacomelli L, et al
    Prevalence of thyroid nodules and thyroid cancer in individuals with a first-degree family history of non-medullary thyroid cancer: a cross-sectional study based on sonographic screening.
    Thyroid. 2022 Sep 13. doi: 10.1089/thy.2022.0253.
    PubMed     Abstract available


  14. BUI QA, Gunathilake M, Lee J, Lee EK, et al
    Relationship between physical activity levels and thyroid cancer risk: A prospective cohort study in Korea.
    Thyroid. 2022 Sep 7. doi: 10.1089/thy.2022.0250.
    PubMed     Abstract available


  15. SUZUKI S, Suzuki S, Iwadate M, Matsuzuka T, et al
    Possible association between thyroid nodule formation and developmental alterations in the pituitary-thyroid hormone axis in children and adolescents: The Fukushima Health Management Survey.
    Thyroid. 2022 Sep 6. doi: 10.1089/thy.2022.0327.
    PubMed     Abstract available


  16. EGAN C, Stefanova D, Thiesmeyer JW, Lee YJ, et al
    Proposed Risk Stratification and Patterns of Radioactive Iodine Therapy in Malignant Struma Ovarii.
    Thyroid. 2022;32:1101-1108.
    PubMed     Abstract available


    August 2022
  17. DIGENNARO C, Vahdat V, Jalali M, Toumi A, et al
    Assessing Bias and Limitations of Clinical Validation Studies of Molecular Diagnostic Tests for Indeterminate Thyroid Nodules: Systematic Review and Meta-Analysis.
    Thyroid. 2022 Aug 23. doi: 10.1089/thy.2022.0269.
    PubMed     Abstract available


  18. BAL C, Satapathy S, Tupalli A, Ballal S, et al
    Propensity Score Matched Outcome Analysis of Lobar Ablation versus Completion Thyroidectomy in Low-risk Differentiated Thyroid Cancer Patients: Median Follow-up of 11 Years.
    Thyroid. 2022 Aug 18. doi: 10.1089/thy.2022.0234.
    PubMed     Abstract available


  19. NIGAM A, Xu B, Spanheimer P, Ganly I, et al
    Tumor Grade Predicts for Calcitonin Doubling Times and Disease-Specific Outcomes After Resection of Medullary Thyroid Carcinoma.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0217.
    PubMed     Abstract available


  20. KIM S, Song SH, Lee CW, Kwon JT, et al
    Low-level environmental mercury exposure and thyroid cancer risk among residents living near national industrial complexes in South Korea: A population-based cohort study.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0084.
    PubMed     Abstract available


  21. BROSE M, Smit J, Lin CC, Tori M, et al
    Multi-kinase Inhibitors for the Treatment of Asymptomatic Radioactive Iodine-Refractory Differentiated Thyroid Cancer: Global, Non-Interventional Study (RIFTOS MKI).
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0061.
    PubMed     Abstract available


  22. KEEFE G, Culbreath K, Cherella CE, Smith JR, et al
    Autoimmune Thyroiditis and Risk of Malignancy in Children with Thyroid Nodules.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0241.
    PubMed     Abstract available


  23. KUCHARECZKO A, Kopczynski J, Kowalik A, Hincza-Nowak K, et al
    A significance of concomitant BRAFV600E and TERT mutations in Polish patients with papillary thyroid microcarcinoma - a retrospective cohort study based on 430 cases.
    Thyroid. 2022 Aug 11. doi: 10.1089/thy.2022.0155.
    PubMed     Abstract available


  24. LI C, Gao Y, Zhou P, Yue T, et al
    Comparison of the robotic bilateral axillo-breast approach and conventional open thyroidectomy in pediatric patients: a retrospective cohort study.
    Thyroid. 2022 Aug 9. doi: 10.1089/thy.2022.0242.
    PubMed     Abstract available


  25. FINKELSTEIN S, Sistrunk J, Malchoff C, Thompson DV, et al
    A Retrospective Evaluation of the Diagnostic Performance of an Interdependent Pairwise microRNA Expression Analysis with a Mutation Panel in Indeterminate Thyroid Nodules.
    Thyroid. 2022 Aug 9. doi: 10.1089/thy.2022.0124.
    PubMed     Abstract available


    July 2022
  26. JERKOVICH F, Abelleira E, Bueno F, Guerrero L, et al
    Active surveillance of small metastatic lymph nodes as an alternative to surgery in selected patients with low risk papillary thyroid cancer: A retrospective cohort study.
    Thyroid. 2022 Jul 25. doi: 10.1089/thy.2022.0302.
    PubMed     Abstract available


  27. METE O, Asa SL
    Oncologic Outcome Prediction in Differentiated Thyroid Carcinoma: Assumption or Improved Accuracy?
    Thyroid. 2022 Jul 15. doi: 10.1089/thy.2022.0379.
    PubMed     Abstract available


  28. DOOLITTLE WKL, Zhao L, Cheng SY
    Blocking CDK7-mediated NOTCH1-cMYC Signaling Attenuates Cancer Stem Cell Activity in Anaplastic Thyroid Cancer.
    Thyroid. 2022 Jul 13. doi: 10.1089/thy.2022.0087.
    PubMed     Abstract available


  29. CORSELLO A, Ramunno V, Locantore P, Pacini G, et al
    Medullary Thyroid Cancer with Ectopic Cushing's Syndrome: A Case Report and Systematic Review of Detailed Cases from the Literature.
    Thyroid. 2022 Jul 12. doi: 10.1089/thy.2021.0696.
    PubMed     Abstract available


  30. RANDOLPH GW, Sosa JA, Hao Y, Angell TE, et al
    Preoperative Identification of Medullary Thyroid Carcinoma (MTC): Clinical Validation of the Afirma MTC RNA-Sequencing Classifier.
    Thyroid. 2022 Jul 6. doi: 10.1089/thy.2022.0189.
    PubMed     Abstract available


    June 2022
  31. PLITT G, Brewer T, Yehia L, Jin J, et al
    Development and progression of thyroid disease in PTEN hamartoma tumor syndrome: refined surveillance recommendations.
    Thyroid. 2022 Jun 27. doi: 10.1089/thy.2022.0181.
    PubMed     Abstract available


  32. NOTO B, Asmus I, Schafers M, Goerlich D, et al
    Predictors of anxiety and depression in differentiated thyroid cancer survivors: Results of a cross-sectional Study.
    Thyroid. 2022 Jun 23. doi: 10.1089/thy.2022.0067.
    PubMed     Abstract available


  33. PAPACHRISTOS AJ, Do K, Tsang V, Sywak M, et al
    Outcomes of papillary thyroid microcarcinoma presenting with palpable lateral lymphadenopathy.
    Thyroid. 2022 Jun 15. doi: 10.1089/thy.2022.0109.
    PubMed     Abstract available


  34. HWANGBO Y, Choi JY, Lee EK, Ryu CH, et al
    A cross-sectional survey of patient treatment choice in a multicenter prospective cohort study on active surveillance of papillary thyroid microcarcinoma (MAeSTro).
    Thyroid. 2022 Jun 13. doi: 10.1089/thy.2021.0619.
    PubMed     Abstract available


  35. BUSAIDY N, Konda B, Wei L, Wirth LJ, et al
    Dabrafenib vs dabrafenib + trametinib in BRAF-mutated radioactive iodine refractory differentiated thyroid cancer - results of a randomized, phase 2, open-label, multicenter trial.
    Thyroid. 2022 Jun 4. doi: 10.1089/thy.2022.0115.
    PubMed     Abstract available


    May 2022
  36. WIJEWARDENE A, Gill AJ, Gild M, Learoyd DL, et al
    A retrospective cohort study with prospective validation of predictors of differentiated thyroid cancer outcomes.
    Thyroid. 2022 May 27. doi: 10.1089/thy.2021.0563.
    PubMed     Abstract available


  37. HU TX, Nguyen DT, Patel MK, Beckett K, et al
    The Effect Modification of Ultrasound Risk Classification on Molecular Testing in Predicting the Risk of Malignancy in Cytologically Indeterminate Thyroid Nodules.
    Thyroid. 2022 May 25. doi: 10.1089/thy.2021.0659.
    PubMed     Abstract available


  38. ERICKSON T, Shih YP, Fass J, Jang M, et al
    T cells engineered to express immunoreceptors targeting the frequently expressed medullary thyroid cancer antigens calcitonin, CEA and RET M918T.
    Thyroid. 2022 May 19. doi: 10.1089/thy.2022.0020.
    PubMed     Abstract available


  39. HATASHIMA A, Archambeau B, Armbruster H, Xu M, et al
    An Evaluation of Clinical Efficacy of Immune Checkpoint Inhibitors for Patients with Anaplastic Thyroid Carcinoma.
    Thyroid. 2022 May 18. doi: 10.1089/thy.2022.0073.
    PubMed     Abstract available


  40. KIM K, Choi JY, Kim SJ, Lee EK, et al
    Active Surveillance Versus Immediate Surgery for Low-Risk Papillary Thyroid Microcarcinoma Patients in South Korea: A Cost-Minimization Analysis from the MAeSTro Study.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0679.
    PubMed     Abstract available


  41. YI W, Kim BH, Kim M, Kim J, et al
    Heart failure and stroke risks in users of liothyronine with or without levothyroxine compared to levothyroxine alone: A propensity score matched analysis.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0634.
    PubMed     Abstract available


  42. SORENSEN JR, Dossing H, Watt T, Cramon PK, et al
    The effect of laser thermal ablation on quality of life: Improvements in patients with solid-cystic thyroid nodules.
    Thyroid. 2022 May 16. doi: 10.1089/thy.2021.0665.
    PubMed     Abstract available


  43. LEE NY, Riaz N, Wu V, Brinkman T, et al
    A Pilot Study of Durvalumab (MEDI4736) with Tremelimumab in Combination with Image Guided Stereotactic Body Radiotherapy (SBRT) in the Treatment of Metastatic Anaplastic Thyroid Cancer.
    Thyroid. 2022 May 6. doi: 10.1089/thy.2022.0050.
    PubMed     Abstract available


    April 2022
  44. TOFT DJ, Schneider AB
    PROTECTING THE THYROID IN TIMES OF CONFLICT (UKRAINE 2022).
    Thyroid. 2022 Apr 25. doi: 10.1089/thy.2022.0135.
    PubMed     Abstract available


  45. SORENSEN SM, De la Cour CD, Maltesen T, Urbute A, et al
    Temporal trends in papillary and follicular thyroid cancer incidence from 1995 to 2019 in adults in Denmark according to education and income.
    Thyroid. 2022 Apr 22. doi: 10.1089/thy.2021.0602.
    PubMed     Abstract available


  46. KIM M, Jin M, Jeon MJ, Kim EY, et al
    Lenvatinib compared with sorafenib as a first-line treatment for radioactive iodinerefractory, progressive, differentiated thyroid carcinoma: Real-world outcomes in a multicenter retrospective cohort study.
    Thyroid. 2022 Apr 20. doi: 10.1089/thy.2022.0054.
    PubMed     Abstract available


  47. WEI J, Thwin M, Nickel B, Glover AR, et al
    Factors which inform individual decision making between active surveillance, hemithyroidectomy and total thyroidectomy for low-risk thyroid cancer: A scoping review.
    Thyroid. 2022 Apr 19. doi: 10.1089/thy.2021.0646.
    PubMed     Abstract available


  48. CHOU R, Dana T, Brent GA, Goldner W, et al
    Serum Thyroglobulin Measurement Following Surgery without Radioactive Iodine for Differentiated Thyroid Cancer: A Systematic Review.
    Thyroid. 2022 Apr 12. doi: 10.1089/thy.2021.0666.
    PubMed     Abstract available


  49. CAPDEVILA J, Klochikhin A, Leboulleux S, Isaev P, et al
    A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg per Day Compared with the Cabozantinib Capsule at 140 mg per Day in Patients With Progressive, Metastatic Medullary Thyroid Cancer.
    Thyroid. 2022 Apr 10. doi: 10.1089/thy.2022.0027.
    PubMed     Abstract available


    March 2022
  50. WANG Z, Tang C, Wang Y, Yin Z, et al
    Inclusion of the Number of Metastatic Lymph Nodes in the Staging System for Medullary Thyroid Cancer: Validating a Modified AJCC TNM Staging System.
    Thyroid. 2022 Mar 30. doi: 10.1089/thy.2021.0571.
    PubMed     Abstract available


  51. ZHANG F, Teng D, Tong N, Wang G, et al
    Gender-Specific Associations Between Metabolic Disorders and Thyroid Nodules: A Cross-Sectional Population-Based Study From China.
    Thyroid. 2022 Mar 23. doi: 10.1089/thy.2021.0686.
    PubMed     Abstract available


  52. MA LX, Espin-Garcia O, Bedard PL, Stockley TL, et al
    Clinical Application of Next-Generation Sequencing in Advanced Thyroid Cancers.
    Thyroid. 2022 Mar 9. doi: 10.1089/thy.2021.0542.
    PubMed     Abstract available


  53. YEO Y, Shin DW, Han K, Kim D, et al
    Smoking, alcohol consumption, and the risk of thyroid cancer: a population-based Korean cohort study of 10 million people.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0675.
    PubMed     Abstract available


  54. MURI R, Trippel M, Borner U, Weidner SE, et al
    The impact of rapid on-site evaluation (ROSE) on the quality and diagnostic value of thyroid nodule fine-needle aspirations.
    Thyroid. 2022 Mar 2. doi: 10.1089/thy.2021.0551.
    PubMed     Abstract available


  55. MATSUURA D, Yuan A, Wang L, Ranganath R, et al
    Follicular and Hurthle Cell Carcinoma: Comparison of Clinicopathological Features and Clinical Outcomes.
    Thyroid. 2022;32:245-254.
    PubMed     Abstract available


  56. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Response to "Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries" by Kao.
    Thyroid. 2022;32:342-343.
    PubMed    


  57. KAO YH
    Letter to the Editor: Radioiodine Is Molecular Radiotherapy Governed by Predictable Deterministic Radiobiology Expressed in Gray, Not Millicuries.
    Thyroid. 2022;32:340-341.
    PubMed    


  58. SUZUKI N, Watanabe N, Noh JY, Yoshimura R, et al
    The relationship between primary thyroid lymphoma and various types of thyroid autoimmunity: A retrospective cohort study of 498 cases, including 9 cases with Graves' disease.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0613.
    PubMed     Abstract available


  59. HOANG JK, Asadollahi S, Durante C, Hegedus L, et al
    An International Survey on Utilization of Five Thyroid Nodule Risk Stratification Systems: A Needs Assessment with Future Implications.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0558.
    PubMed     Abstract available


  60. BLOMAIN ES, Berta S, Hug NF, Giao DM, et al
    Radiotherapy for brain metastases from thyroid cancer: an institutional and national retrospective cohort study.
    Thyroid. 2022 Mar 1. doi: 10.1089/thy.2021.0628.
    PubMed     Abstract available


    February 2022
  61. HSIAO V, Arroyo N, Fernandes-Taylor S, Chiu AS, et al
    Sensitivity of Palpation for Detection of Thyroid Nodules with Attention to Size.
    Thyroid. 2022 Feb 25. doi: 10.1089/thy.2021.0692.
    PubMed     Abstract available


  62. JONKLAAS J
    Impact of Nasolacrimal Dysfunction in Thyroid Cancer Survivors.
    Thyroid. 2022 Feb 18. doi: 10.1089/thy.2022.0095.
    PubMed     Abstract available


  63. GROUSSIN L, Theodon H, Bessiene L, Bricaire L, et al
    Redifferentiating effect of larotrectinib in NTRK-rearranged advanced radioactive-iodine refractory thyroid cancer.
    Thyroid. 2022 Feb 16. doi: 10.1089/thy.2021.0524.
    PubMed     Abstract available


  64. MEGWALU U, Moon PK
    Thyroid Cancer Incidence and Mortality Trends in the United States: 2000 - 2018.
    Thyroid. 2022 Feb 8. doi: 10.1089/thy.2021.0662.
    PubMed     Abstract available


    January 2022
  65. CHOU R, Dana T, Haymart MR, Leung AM, et al
    Active surveillance versus thyroid surgery for differentiated thyroid cancer: A systematic review.
    Thyroid. 2022 Jan 26. doi: 10.1089/thy.2021.0539.
    PubMed     Abstract available


  66. PASQUAL E, Sosa JA, Chen Y, Schonfeld SJ, et al
    Trends in the management of localized papillary thyroid cancer in the United States (2000-2018).
    Thyroid. 2022 Jan 25. doi: 10.1089/thy.2021.0557.
    PubMed     Abstract available


  67. TCHEKMEDYIAN V, Dunn L, Sherman EJ, Baxi SS, et al
    Enhancing Radioiodine Incorporation in BRAF-Mutant, Radioiodine-Refractory Thyroid Cancers with Vemurafenib and the Anti-ErbB3 Monoclonal Antibody CDX-3379: Results of a Pilot Clinical Trial.
    Thyroid. 2022 Jan 19. doi: 10.1089/thy.2021.0565.
    PubMed     Abstract available


  68. STAGNARO-GREEN A
    Thyroid Disease in Pregnancy: A Touch of Clarity.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0668.
    PubMed     Abstract available


  69. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    A quantitative analysis examining patients' choice of active surveillance or surgery for managing low risk papillary thyroid cancer.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0485.
    PubMed     Abstract available


  70. PIERANNUNZIO D, Fedeli U, Francisci S, De Paoli A, et al
    Thyroidectomies in Italy: A population-based national analysis from 2001 to 2018.
    Thyroid. 2022 Jan 12. doi: 10.1089/thy.2021.0531.
    PubMed     Abstract available


    December 2021
  71. SHOBAB L, Burman KD, Wartofsky L
    Sex Differences in Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 31. doi: 10.1089/thy.2021.0361.
    PubMed     Abstract available


  72. HESS J, Newbern DK, Beebe KL, Walsh AM, et al
    High prevalence of gene fusions and copy number alterations in pediatric radiation therapy-induced papillary and follicular thyroid carcinomas.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0217.
    PubMed     Abstract available


  73. SHIN A, Cho S, Jang D, Abe SK, et al
    Body mass index and thyroid cancer risk - A pooled analysis of half a million men and women in the Asia Cohort Consortium.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0445.
    PubMed     Abstract available


  74. MEHTA V, Naraparaju A, Liao D, Davies L, et al
    What's in a Name? A Cost-Effectiveness Analysis of the Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features (NIFTP) Nomenclature Revision.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0486.
    PubMed     Abstract available


  75. MOLLEN K, Shaffer AD, Yip L, Monaco S, et al
    Unique Molecular Signatures are Associated with Aggressive Histology in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0317.
    PubMed     Abstract available


  76. LIWEN L, Xinguang Q
    Safety and efficacy of ultrasound-guided radiofrequency ablation for benign nonfunctional thyroid nodules in children: a retrospective study of 62 patients with over 4 years of follow-up.
    Thyroid. 2021 Dec 16. doi: 10.1089/thy.2021.0454.
    PubMed     Abstract available


  77. LEE JY, Woo KI
    Surgical risk prediction for nasolacrimal duct obstruction in radioactive iodine treated thyroid cancer: A nationwide cohort study.
    Thyroid. 2021 Dec 12. doi: 10.1089/thy.2021.0418.
    PubMed     Abstract available


  78. MATSUURA D, Yuan A, Harries V, Shaha AR MD, et al
    Surgical Management of Low-/Intermediate-Risk Node Negative Thyroid Cancer: A Single-Institution Study Using Propensity Matching Analysis to Compare Thyroid Lobectomy and Total Thyroidectomy.
    Thyroid. 2021 Dec 3. doi: 10.1089/thy.2021.0356.
    PubMed     Abstract available


    November 2021
  79. BISCHOFF L, Haymart MR
    Optimal TSH following lobectomy for papillary thyroid cancer: Does it exist?
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0617.
    PubMed     Abstract available


  80. DI CRISTOFANO A
    The Year in Basic Thyroid Cancer Research.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0561.
    PubMed     Abstract available


  81. HAYMART MR
    Year in Thyroidology- Recent Developments and Future Challenges: Clinical Science Review.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0562.
    PubMed     Abstract available


  82. JONGEJAN RMS, van Velsen EFS, Meima ME, Klein T, et al
    Change in Thyroid Hormone Metabolite concentrations across Different Thyroid States.
    Thyroid. 2021 Nov 22. doi: 10.1089/thy.2021.0453.
    PubMed     Abstract available


  83. ROBENSHTOK E, Neeman B, Reches L, Ritter A, et al
    Adverse Histological Features of Differentiated Thyroid Cancer are Commonly Found in Autopsy Studies: Implications for Treatment Guidelines.
    Thyroid. 2021 Nov 13. doi: 10.1089/thy.2021.0268.
    PubMed     Abstract available


  84. SHIMURA H, Matsuzuka T, Suzuki S, Iwadate M, et al
    Fine Needle Aspiration Cytology Implementation and Malignancy Rates in Children and Adolescents Based on Japanese Guidelines: The Fukushima Health Management Survey.
    Thyroid. 2021;31:1683-1692.
    PubMed     Abstract available


    October 2021
  85. BARAN J, Bauer AJ, Halada SJ, Mostoufi-Moab S, et al
    Clinical Course of Early Postoperative Hypothyroidism Following Thyroid Lobectomy in Pediatrics.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0396.
    PubMed     Abstract available


  86. NEWMAN SK, Harries V, Wang LY, McGill MR, et al
    Invasion of a Recurrent Laryngeal Nerve from Small, Well-Differentiated Papillary Thyroid Cancers: Patient Selection Implications for Active Surveillance.
    Thyroid. 2021 Oct 29. doi: 10.1089/thy.2021.0310.
    PubMed     Abstract available


  87. MONTI S, Presciuttini F, Deiana MG, Motta C, et al
    Cortisol deficiency in Lenvatinib treatment of thyroid cancer: an underestimated, common adverse event.
    Thyroid. 2021 Oct 19. doi: 10.1089/thy.2021.0040.
    PubMed     Abstract available


  88. BERTOL BC, Bales ES, Calhoun JD, Mayberry A, et al
    Lenvatinib plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0371.
    PubMed     Abstract available


  89. PITT SC, Saucke MC, Roman BR, Alexander SC, et al
    The Influence of Emotions on Treatment Decisions about Low-Risk Thyroid Cancer: A Qualitative Study.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0323.
    PubMed     Abstract available


  90. BALLAL S, Yadav MP, Moon ES, Roesch F, et al
    Novel Fibroblast Activation Protein Inhibitor-Based targeted Theranostics for Radioiodine Refractory differentiated Thyroid Cancer Patients: A Pilot Study.
    Thyroid. 2021 Oct 12. doi: 10.1089/thy.2021.0412.
    PubMed     Abstract available


  91. XU S, Huang Y, Huang H, Zhang X, et al
    Optimal serum thyroid-stimulating hormone level for patients with papillary thyroid carcinoma after lobectomy.
    Thyroid. 2021 Oct 7. doi: 10.1089/thy.2021.0404.
    PubMed     Abstract available


  92. HUANG NS, Wei WJ, Xiang J, Chen JY, et al
    The Efficacy and Safety of Anlotinib in Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Single-arm Phase II Clinical Trial.
    Thyroid. 2021 Oct 6. doi: 10.1089/thy.2021.0307.
    PubMed     Abstract available


  93. RANA C, Vuong HG, Nguyen TQ, Nguyen HC, et al
    The Incidence of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: A Meta-Analysis Assessing Worldwide Impact of the Reclassification.
    Thyroid. 2021;31:1502-1513.
    PubMed     Abstract available


    September 2021
  94. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Cutoff age between pediatric and adult thyroid differentiated cancer: Is 18 years old appropriate?
    Thyroid. 2021 Sep 22. doi: 10.1089/thy.2021.0255.
    PubMed     Abstract available


  95. FORLEO R, Grani G, Alfo M, Zilioli V, et al
    Minimal Extrathyroidal Extension in Predicting 1-Year Outcomes: A Longitudinal Multicenter Study of Low-to-Intermediate-Risk Papillary Thyroid Carcinoma (ITCO#4).
    Thyroid. 2021 Sep 19. doi: 10.1089/thy.2021.0248.
    PubMed     Abstract available


  96. SATO A, Tanabe M, Tsuboi Y, Niwa T, et al
    Circulating tumor DNA harboring the BRAF V600E mutation may predict poor outcomes of primary papillary thyroid cancer patients.
    Thyroid. 2021 Sep 19. doi: 10.1089/thy.2021.0267.
    PubMed     Abstract available


  97. DEKKER BL, Muller Kobold AC, Brouwers AH, Williams GRR, et al
    Bone Mineral Density in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma: a longitudinal follow-up study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0179.
    PubMed     Abstract available


  98. GUO K, Qian K, Shi Y, Sun T, et al
    Clinical and Molecular Characterizations of Papillary Thyroid Cancer in Children and Young Adults: a Multicenter Retrospective Study.
    Thyroid. 2021 Sep 13. doi: 10.1089/thy.2021.0003.
    PubMed     Abstract available


  99. TESSLER FN
    American Thyroid Association Non-Classifiable Thyroid Nodules: A New Perspective.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0449.
    PubMed     Abstract available


  100. MA T, Semsarian CR, Barratt A, Parker L, et al
    Rethinking low risk micropapillary thyroid cancer: an evidence review for recalibrating diagnostic thresholds and/or alternative labels.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0274.
    PubMed     Abstract available


  101. HO AS, Luu M, Shafqat I, Mallen-St Clair J, et al
    Predictive impact of metastatic lymph node burden on distant metastasis across papillary thyroid cancer variants.
    Thyroid. 2021 Sep 2. doi: 10.1089/thy.2021.0131.
    PubMed     Abstract available


    August 2021
  102. KIM HJ, Chung SM, Kim H, Jang JY, et al
    Long-term efficacy of ultrasound-guided laser ablation for papillary thyroid microcarcinoma: Results of a 10-year retrospective study.
    Thyroid. 2021 Aug 27. doi: 10.1089/thy.2021.0151.
    PubMed     Abstract available


  103. KOEHLER VF, Berg E, Adam P, Weber GL, et al
    Real world efficacy and safety of multi-tyrosine kinase inhibitors in radioiodine refractory thyroid cancer.
    Thyroid. 2021 Aug 18. doi: 10.1089/thy.2021.0091.
    PubMed     Abstract available


  104. GROUSSIN L, Bessiene L, Arrondeau J, Garinet S, et al
    Selpercatinib-Enhanced Radioiodine Uptake in RET-Rearranged Thyroid Cancer.
    Thyroid. 2021 Aug 18. doi: 10.1089/thy.2021.0144.
    PubMed     Abstract available


  105. XU S, Huang H, Zhang X, Huang Y, et al
    Predictive value of serum thyroglobulin for structural recurrence following lobectomy for papillary thyroid carcinoma.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0209.
    PubMed     Abstract available


  106. FIGGE JJ, Gooding WE, Steward DL, Yip L, et al
    Do Ultrasound Patterns and Clinical Parameters Inform the Probability of Thyroid Cancer Predicted by Molecular Testing in Nodules with Indeterminate Cytology?
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0119.
    PubMed     Abstract available


  107. PIEK MW, de Boer JP, Vriens MR, van Leeuwaarde RS, et al
    Retrospective analyses of 18FDG-PET/CT thyroid incidentaloma in adults: incidence, treatment and outcome in a tertiary cancer referral center.
    Thyroid. 2021 Aug 3. doi: 10.1089/thy.2021.0226.
    PubMed     Abstract available


    July 2021
  108. KOBALY K, Kim CS, Langer JE, Mandel SJ, et al
    Macrocalcifications Do Not Alter Malignancy Risk Within the American Thyroid Association Sonographic Pattern System When Present in Non-High Suspicion Thyroid Nodules.
    Thyroid. 2021 Jul 27. doi: 10.1089/thy.2021.0140.
    PubMed     Abstract available


  109. OKAZAKI-HADA M, Maruoka A, Yamamoto M, Ito M, et al
    Poorly differentiated thyroid carcinoma coexisting with Graves' disease involving T3 thyrotoxicosis due to increased D1 and D2 activities.
    Thyroid. 2021 Jul 18. doi: 10.1089/thy.2021.0082.
    PubMed     Abstract available


  110. YAN L, Zhang M, Song Q, Luo Y, et al
    Ultrasound-Guided Radiofrequency Ablation Versus Thyroid Lobectomy for Low-Risk Papillary Thyroid Microcarcinoma: A Propensity-matched Cohort Study of 884 Patients.
    Thyroid. 2021 Jul 16. doi: 10.1089/thy.2021.0100.
    PubMed     Abstract available


  111. JIN M, Kim HI, Ha J, Jeon MJ, et al
    Tumor Volume Doubling Time in Active Surveillance of Papillary Thyroid Microcarcinoma: A Multicenter Cohort Study in Korea.
    Thyroid. 2021 Jul 6. doi: 10.1089/thy.2021.0094.
    PubMed     Abstract available


    June 2021
  112. SIMOES-PEREIRA J, C Ferreira T, Limbert E, Cavaco BM, et al
    Outcomes of thyrotropin alfa vs. levothyroxine withdrawal-aided radioiodine therapy for distant metastasis of papillary thyroid cancer.
    Thyroid. 2021 Jun 22. doi: 10.1089/thy.2021.0013.
    PubMed     Abstract available


  113. RYDER M, Wentworth M, Algeciras-Schimnich A, Morris JC 3rd, et al
    Blocking the TSH receptor with K1-70 in a patient with follicular thyroid cancer, Graves' disease and Graves' ophthalmopathy.
    Thyroid. 2021 Jun 11. doi: 10.1089/thy.2021.0053.
    PubMed     Abstract available


  114. GRONLUND MP, Schmidt Jensen J, Hahn CH, Gronhoj C, et al
    Risk factors for recurrence of follicular thyroid cancer: A systematic review.
    Thyroid. 2021 Jun 9. doi: 10.1089/thy.2020.0921.
    PubMed     Abstract available


  115. EGAN CE, Stefanova D, Ahmed A, Raja VJ, et al
    CSPG4 is a Potential Therapeutic Target in Anaplastic Thyroid Cancer.
    Thyroid. 2021 Jun 3. doi: 10.1089/thy.2021.0067.
    PubMed     Abstract available


    May 2021
  116. BUNEVICIUS A, Fribance S, Pikis S, Lee JYK, et al
    Stereotactic Radiosurgery for Differentiated Thyroid Cancer Brain Metastases: An International, Multicenter Study.
    Thyroid. 2021 May 11. doi: 10.1089/thy.2020.0947.
    PubMed     Abstract available


    April 2021
  117. KIM DH, Kim SW, Kang P, Choi J, et al
    Near-infrared autofluorescence imaging may reduce temporary hypoparathyroidism in patients undergoing total thyroidectomy and central neck dissection.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2021.0056.
    PubMed     Abstract available


  118. MARQUES IJ, Gomes I, Pojo M, Pires C, et al
    Identification of SPRY4 as a novel candidate susceptibility gene for familial non-medullary thyroid cancer.
    Thyroid. 2021 Apr 28. doi: 10.1089/thy.2020.0290.
    PubMed     Abstract available


  119. LUBITZ CC, Sadow PM, Daniels GH, Wirth LJ, et al
    Progress in Treating Advanced Thyroid Cancers in the Era of Targeted Therapy.
    Thyroid. 2021 Apr 16. doi: 10.1089/thy.2020.0962.
    PubMed     Abstract available


  120. VUONG HG, Jung CK, Kakudo K, Bychkov A, et al
    Response to Cherella et al. re: "The use of The Bethesda System for Reporting Thyroid Cytopathology in Pediatric Thyroid Nodules: a meta-analysis".
    Thyroid. 2021 Apr 15. doi: 10.1089/thy.2021.0190.
    PubMed     Abstract available


  121. LEE SB, Cho YJ, Lee S, Choi YH, et al
    Korean Society of Thyroid Radiology (KSThR) guidelines for the management of pediatric thyroid nodules: Suitability and risk factors.
    Thyroid. 2021 Apr 9. doi: 10.1089/thy.2020.0875.
    PubMed     Abstract available


  122. CHERELLA CE, Cibas ES, Wassner AJ
    Re: "The use of the Bethesda System for Reporting Thyroid Cytopathology in pediatric thyroid nodules - A meta-analysis" by Vuong, et al.
    Thyroid. 2021 Apr 5. doi: 10.1089/thy.2021.0116.
    PubMed     Abstract available


  123. NISHINO M, Mateo R, Kilim H, Feldman A, et al
    Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing.
    Thyroid. 2021 Apr 3. doi: 10.1089/thy.2020.0969.
    PubMed     Abstract available


  124. KAYA C, Dorsaint P, Mercurio S, Campbell AM, et al
    Limitations of Detecting Genetic Variants from the RNA Sequencing Data in Tissue and Fine-Needle Aspiration Samples.
    Thyroid. 2021;31:589-595.
    PubMed     Abstract available


  125. GULEC SA, Ahuja S, Avram A, Bernet V, et al
    A JOINT STATEMENT FROM THE AMERICAN THYROID ASSOCIATION, THE EUROPEAN ASSOCIATION OF NUCLEAR MEDICINE, THE EUROPEAN THYROID ASSOCIATION, THE SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING ON CURRENT DIAGNOSTIC AND THERANOSTIC APPROACHES IN THE MANA
    Thyroid. 2021 Apr 1. doi: 10.1089/thy.2020.0826.
    PubMed     Abstract available


    March 2021
  126. PAPALEONTIOU M, Chen D, Banerjee M, Reyes-Gastelum D, et al
    TSH Suppression for Papillary Thyroid Cancer: A Physician Survey Study.
    Thyroid. 2021 Mar 27. doi: 10.1089/thy.2021.0033.
    PubMed     Abstract available


  127. GORTAKOWSKI M, Feghali K, Osakwe IN
    SINGLE INSTITUTION EXPERIENCE WITH AFIRMA AND THYROSEQ TESTING IN INDETERMINATE THYROID NODULES.
    Thyroid. 2021 Mar 25. doi: 10.1089/thy.2020.0801.
    PubMed     Abstract available


  128. PAPALEONTIOU M, Norton EC, Reyes-Gastelum D, Banerjee M, et al
    Competing Causes of Death in Older Adults with Thyroid Cancer.
    Thyroid. 2021 Mar 25. doi: 10.1089/thy.2020.0929.
    PubMed     Abstract available


  129. BIBLE KC, Kebebew E, Brierley J, Brito JP, et al
    2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer.
    Thyroid. 2021;31:337-386.
    PubMed     Abstract available


    February 2021
  130. TAYLOR MH, Takahashi S, Capdevila J, Tahara M, et al
    Correlation of Performance Status and Neutrophil-Lymphocyte Ratio With Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated With Lenvatinib.
    Thyroid. 2021 Feb 26. doi: 10.1089/thy.2020.0779.
    PubMed     Abstract available


  131. MATHEW A, Latteyer S, Frank-Raue K, Moeller LC, et al
    A Novel Double RET E768D/L790F Mutation Associated with a MEN2B-Like Phenotype.
    Thyroid. 2021;31:327-329.
    PubMed     Abstract available


  132. GRANI G, Zatelli MC, Alfo M, Montesano T, et al
    Real-World Performance of the American Thyroid Association Risk Estimates in Predicting 1-Year Differentiated Thyroid Cancer Outcomes: A Prospective Multicenter Study of 2000 Patients.
    Thyroid. 2021;31:264-271.
    PubMed     Abstract available


    January 2021
  133. VUONG HGG, Chung DGB, Ngo LM, Bui TQ, et al
    The use of the Bethesda system for reporting thyroid cytopathology in pediatric thyroid nodules - A meta-analysis.
    Thyroid. 2021 Jan 27. doi: 10.1089/thy.2020.0702.
    PubMed     Abstract available


  134. VAN VELSEN EFS, Visser WE, Stegenga MT, Maeder U, et al
    Finding the Optimal Age Cutoff for the UICC/AJCC TNM Staging System in Patients with Papillary or Follicular Thyroid Cancer.
    Thyroid. 2021 Jan 23. doi: 10.1089/thy.2020.0615.
    PubMed     Abstract available


  135. MORARIU EM, McCoy KL, Chiosea SI, Nikitski AV, et al
    Clinicopathologic Characteristics of Thyroid Nodules Positive for the THADA-IGF2BP3 Fusion on Preoperative Molecular Analysis.
    Thyroid. 2021 Jan 23. doi: 10.1089/thy.2020.0589.
    PubMed     Abstract available


  136. LONCAR I, van Dijk SPJ, Metman MJH, Lin JF, et al
    Active surveillance for papillary thyroid microcarcinoma in a population with restrictive diagnostic work-up strategies.
    Thyroid. 2021 Jan 11. doi: 10.1089/thy.2020.0845.
    PubMed     Abstract available


    December 2020
  137. CONDELLO V, Nikitski AV, Foulkes W, Nikiforov YE, et al
    Prevalence of WWP1 Gene Mutations in Patients with Thyroid Nodules.
    Thyroid. 2020 Dec 29. doi: 10.1089/thy.2020.0919.
    PubMed     Abstract available


  138. NG DL, van Zante A, Griffin A, Hills NK, et al
    A large thyroid fine needle aspiration biopsy cohort with long-term population-based follow-up.
    Thyroid. 2020 Dec 28. doi: 10.1089/thy.2020.0689.
    PubMed     Abstract available


  139. CHUNG SR, Choi YJ, Lee SS, Kim SO, et al
    Interobserver Reproducibility in Sonographic Measurement of Diameter and Volume of Papillary Thyroid Microcarinoma.
    Thyroid. 2020 Dec 7. doi: 10.1089/thy.2020.0317.
    PubMed     Abstract available


  140. TOUMI A, DiGennaro C, Vahdat V, Jalali M, et al
    Trends in Thyroid Surgery and Guideline-Concordant Care in the United States, 2007-2018.
    Thyroid. 2020 Dec 5. doi: 10.1089/thy.2020.0643.
    PubMed     Abstract available


    November 2020
  141. KANG YE, Kim JM, Lim MA, Lee SE, et al
    Growth differentiation factor 15 is a cancer cell-induced mitokine that primes thyroid cancer cells for invasiveness.
    Thyroid. 2020 Nov 30. doi: 10.1089/thy.2020.0034.
    PubMed     Abstract available


  142. SHIH P, Nickel B, Degeling C, Thomas R, et al
    Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: Results from three Australian community juries.
    Thyroid. 2020 Nov 25. doi: 10.1089/thy.2020.0694.
    PubMed     Abstract available


  143. LORUSSO L, Romei C, Piaggi P, Fustini C, et al
    Ca19.9 positivity and doubling time are prognostic factors of mortality in patients with advanced medullary thyroid cancer with no evidence of structural disease progression according to RECIST.
    Thyroid. 2020 Nov 24. doi: 10.1089/thy.2020.0060.
    PubMed     Abstract available


  144. LANDA I
    PLEKHS1 mutations in thyroid cancers.
    Thyroid. 2020 Nov 15. doi: 10.1089/thy.2020.0728.
    PubMed     Abstract available


  145. CIAPPUCCINI R, Licaj I, Lasne-Cardon A, Babin E, et al
    18F-Fluorocholine PET/CT is a highly sensitive but poorly specific tool for identifying malignancy in thyroid nodules with indeterminate cytology: The Chocolate study.
    Thyroid. 2020 Nov 12. doi: 10.1089/thy.2020.0555.
    PubMed     Abstract available


  146. RAMIREZ-MOYA J, Santisteban P
    A positive feedback loop between DICER1 and differentiation transcription factors is important for thyroid tumorigenesis.
    Thyroid. 2020 Nov 11. doi: 10.1089/thy.2020.0297.
    PubMed     Abstract available


  147. LARCHER DE ALMEIDA AM, Delfim RLC, Vidal APA, Chaves MCDACM, et al
    Combining the American Thyroid Association's ultrasound classification with cytological subcategorization improves the assessment of malignancy risk in indeterminate thyroid nodules.
    Thyroid. 2020 Nov 4. doi: 10.1089/thy.2019.0575.
    PubMed     Abstract available


  148. GUO J, Teng D, Shi X, Li Y, et al
    Exposure to the Chinese Great Famine in early life and thyroid function and disorders in adulthood: a cross-sectional study.
    Thyroid. 2020 Nov 2. doi: 10.1089/thy.2020.0325.
    PubMed     Abstract available


    October 2020
  149. JANMOHAMED N, Segal P, Corrado A, Lofters A, et al
    Endocrinologist perceived factors affecting the transition of thyroid cancer patients from specialist to primary care post-cancer treatment in Ontario, Canada.
    Thyroid. 2020 Oct 29. doi: 10.1089/thy.2020.0413.
    PubMed     Abstract available


  150. LEE YA, Yun HR, Lee J, Moon H, et al
    Trends in Pediatric Thyroid Cancer Incidence, Treatment, and Clinical Course in Korea during 2004-2016: A Nationwide Population-Based Study.
    Thyroid. 2020 Oct 27. doi: 10.1089/thy.2020.0155.
    PubMed     Abstract available


  151. SUGITANI I, Ito Y, Takeuchi D, Nakayama H, et al
    Indications and strategy for active surveillance of adult low-risk papillary thyroid microcarcinoma: consensus statements from the Japan Association of Endocrine Surgery task force on management for papillary thyroid microcarcinoma.
    Thyroid. 2020 Oct 6. doi: 10.1089/thy.2020.0330.
    PubMed     Abstract available


  152. PITT SC, Saucke MC, Wendt EM, Schneider DF, et al
    Patients' Reaction to Diagnosis with Thyroid Cancer or an Indeterminate Thyroid Nodule.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2020.0233.
    PubMed     Abstract available


  153. PIEK MW, Postma EL, van Leeuwaarde R, de Boer JP, et al
    The effect of radioactive iodine therapy on ovarian function and fertility in female thyroid cancer patients: a systematic review and meta-analysis.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2020.0356.
    PubMed     Abstract available


  154. TRAVERSI F, Stooss A, Dettmer MS, Charles RP, et al
    BRAFV600E overrides NOTCH signaling in thyroid cancer.
    Thyroid. 2020 Oct 3. doi: 10.1089/thy.2019.0595.
    PubMed     Abstract available


    September 2020
  155. GIANI C, Valerio L, Bongiovanni A, Durante C, et al
    Safety and quality of life data from an Italian expanded access program of lenvatinib for treatment of thyroid cancer.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0276.
    PubMed     Abstract available


  156. DEZIEL N, Zhang Y, Wang R, Wiemels J, et al
    Birth Characteristics and Risk of Pediatric Thyroid Cancer: A Population-Based Record-Linkage Study in California.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0217.
    PubMed     Abstract available


  157. YANSONG L, Yang H, Ding Y, Cheng Y, et al
    Donafenib in progressive locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer: results of a randomized, multicenter, phase II trial.
    Thyroid. 2020 Sep 10. doi: 10.1089/thy.2020.0235.
    PubMed     Abstract available


    August 2020
  158. CHEN D, Reyes-Gastelum D, Veenstra CM, Hamilton AS, et al
    Financial hardship among Hispanic women with thyroid cancer.
    Thyroid. 2020 Aug 25. doi: 10.1089/thy.2020.0497.
    PubMed     Abstract available


  159. JACOBS D, Breen CT, Pucar D, Holt E, et al
    Changes in Population-Level and Institutional-Level Prescribing Habits of Radioiodine Therapy for Papillary Thyroid Cancer.
    Thyroid. 2020 Aug 18. doi: 10.1089/thy.2020.0237.
    PubMed     Abstract available


  160. SHIN HS, Sun HJ, Whang YM, Park YJ, et al
    Metformin reduces thyroid cancer tumor growth in the metastatic niche of bone by inhibiting osteoblastic RANKL productions.
    Thyroid. 2020 Aug 13. doi: 10.1089/thy.2019.0851.
    PubMed     Abstract available


  161. ZHAO CK, Ren TT, Yin YF, Shi H, et al
    A Comparative Analysis of Two Machine Learning-based Diagnostic Patterns with ACR TI-RADS for Thyroid Nodules: Diagnostic Performance and Unnecessary Biopsy Rate.
    Thyroid. 2020 Aug 11. doi: 10.1089/thy.2020.0305.
    PubMed     Abstract available


  162. KOEHLER V, Adam P, Frank-Raue K, Raue F, et al
    Real world efficacy and safety of cabozantinib and vandetanib in advanced medullary thyroid cancer.
    Thyroid. 2020 Aug 11. doi: 10.1089/thy.2020.0206.
    PubMed     Abstract available


  163. HEGEDUS L, Miyauchi A, Tuttle RM
    Non-surgical thermal ablation of thyroid nodules. Not if, but why, when, and how?
    Thyroid. 2020 Aug 10. doi: 10.1089/thy.2020.0659.
    PubMed     Abstract available


  164. ALLOCCA C, Cirafici AM, Laukkanen MO, Castellone MD, et al
    Serine 897 phosphorylation of EPHA2 is involved in signaling of oncogenic ERK1/2 drivers in thyroid cancer cells.
    Thyroid. 2020 Aug 6. doi: 10.1089/thy.2019.0728.
    PubMed     Abstract available


    July 2020
  165. AGATE L, Puleo L, Giani C, Valerio L, et al
    Symptomatic and asymptomatic biliary disorders during lenvatinib treatment for advanced thyroid cancer is an underestimated problem.
    Thyroid. 2020 Jul 29. doi: 10.1089/thy.2020.0245.
    PubMed     Abstract available


  166. MAINO F, Bufano A, Dalmazio G, Campanile M, et al
    VALIDATION OF AMERICAN THYROID ASSOCIATION ULTRASOUND RISK-ADAPTED APPROACH FOR REPEATING CYTOLOGY IN BENIGN THYROID NODULES.
    Thyroid. 2020 Jul 27. doi: 10.1089/thy.2020.0351.
    PubMed     Abstract available


  167. HERNANDEZ-PRERA J, Valderrabano P, Creed J, de la Iglesia JV, et al
    MOLECULAR DETERMINANTS OF THYROID NODULES WITH INDETERMINATE CYTOLOGY AND RAS MUTATIONS.
    Thyroid. 2020 Jul 21. doi: 10.1089/thy.2019.0650.
    PubMed     Abstract available


  168. SASAKI T, Miyauchi A, Ito Y, Kudo T, et al
    Marked decrease over time in conversion surgery after active surveillance of low-risk papillary thyroid microcarcinoma.
    Thyroid. 2020 Jul 14. doi: 10.1089/thy.2020.0319.
    PubMed     Abstract available


  169. BRUCE JY, Bible KC, Chintakuntlawar A
    Emergence of resistant clones in medullary thyroid cancer may not be rescued by subsequent salvage highly selective RET-inhibitor therapy.
    Thyroid. 2020 Jul 14. doi: 10.1089/thy.2020.0449.
    PubMed     Abstract available


  170. YOON JH, Hong AR, Kim HK, Kang HC, et al
    Anaplastic Thyroid Cancer Arising from Dyshormonogenetic Goiter: c.3070T>C and Novel c.7070T>C Mutation in the Thyroglobulin Gene.
    Thyroid. 2020 Jul 6. doi: 10.1089/thy.2020.0248.
    PubMed     Abstract available


  171. AHN J, Jin M, Song E, Ryu YM, et al
    Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry.
    Thyroid. 2020 Jul 1. doi: 10.1089/thy.2020.0312.
    PubMed     Abstract available


    June 2020
  172. BERNARDI S, Giudici F, Cesareo R, Antonelli G, et al
    Five-year results of radiofrequency and laser ablation of benign thyroid nodules: a multicenter study from the Italian minimally-invasive treatments of the thyroid group.
    Thyroid. 2020 Jun 24. doi: 10.1089/thy.2020.0202.
    PubMed     Abstract available


  173. CHUNG R, Guan H, Ponchiardi C, Cerda SR, et al
    Noninvasive Follicular Thyroid Neoplasm with Papillary-like Nuclear Features (NIFTP): Epidemiology and Long-Term Outcomes in a Strictly-Defined Cohort.
    Thyroid. 2020 Jun 16. doi: 10.1089/thy.2019.0616.
    PubMed     Abstract available


  174. BIBLE KC, Menefee ME, Lin CC, Millward M, et al
    An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer.
    Thyroid. 2020 Jun 14. doi: 10.1089/thy.2019.0269.
    PubMed     Abstract available


  175. PARK JH, Choi M, Kim JH, Kim J, et al
    Metabolic syndrome and the risk of thyroid cancer: A nationwide population-based cohort study.
    Thyroid. 2020 Jun 11. doi: 10.1089/thy.2019.0699.
    PubMed     Abstract available


  176. CERIANI L, Milan L, Virili C, Cascione L, et al
    Radiomics analysis of [18F] fluorodeoxyglucose-avid thyroid incidentalomas improves risk stratification and selection for clinical assessment.
    Thyroid. 2020 Jun 10. doi: 10.1089/thy.2020.0224.
    PubMed     Abstract available


  177. CHESOVER AD, Vali R, Hemmati SH, Wasserman JD, et al
    Lung metastasis in children with differentiated thyroid cancer: factors associated with diagnosis and outcomes of therapy.
    Thyroid. 2020 Jun 10. doi: 10.1089/thy.2020.0002.
    PubMed     Abstract available


  178. ZHU CY, Sha SW, Tseng CH, Yang SE, et al
    Trends in the surgical management of known or suspected differentiated thyroid cancer at a single institution, 2010 - 2018.
    Thyroid. 2020 Jun 9. doi: 10.1089/thy.2019.0783.
    PubMed     Abstract available


  179. GUGNONI M, Manicardi V, Torricelli F, Sauta E, et al
    Linc00941 is a novel TGFbeta target that primes papillary thyroid cancer metastatic behavior by regulating the expression of Cadherin 6.
    Thyroid. 2020 Jun 4. doi: 10.1089/thy.2020.0001.
    PubMed     Abstract available


    May 2020
  180. LEE M, Powers AE, Morris LGT, Marti JL, et al
    Reversal in thyroid cancer incidence trends in the United States, 2000-2017.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0321.
    PubMed     Abstract available


  181. TENG D, Li W, Du J, Wang H, et al
    Effects of MWA on Papillary Thyroid Microcarcinoma: A 5-Year Follow-up Report.
    Thyroid. 2020 May 27. doi: 10.1089/thy.2020.0049.
    PubMed     Abstract available


  182. JEON M, You MH, Han JM, Sim SY, et al
    High phosphoglycerate dehydrogenase expression induces stemness and aggressiveness in thyroid cancer.
    Thyroid. 2020 May 22. doi: 10.1089/thy.2020.0105.
    PubMed     Abstract available


  183. HUGHES E, Rhoads A, Thomas A, Aloi J, et al
    Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER18 2000-2016.
    Thyroid. 2020 May 12. doi: 10.1089/thy.2020.0152.
    PubMed     Abstract available


  184. HODAK SP, Duh QY
    The American Association of Endocrine Surgeons (AAES) Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
    Thyroid. 2020 May 10. doi: 10.1089/thy.2020.0209.
    PubMed     Abstract available


  185. CHO SJ, Baek SM, Lim HK, Lee KD, et al
    Long-term Follow-up Results of Ultrasound-guided Radiofrequency Ablation for Low-risk Papillary Thyroid Microcarcinoma: More than 5 year follow-up for 84 tumors.
    Thyroid. 2020 May 7. doi: 10.1089/thy.2020.0106.
    PubMed     Abstract available


  186. HORVATH E, Skoknic Binder V, Majlis Drinberg S, Tala Jury H, et al
    Radioiodine-induced salivary gland damage detected by ultrasonography in patients treated for papillary thyroid cancer: RAI activity and risk.
    Thyroid. 2020 May 6. doi: 10.1089/thy.2019.0563.
    PubMed     Abstract available


  187. AROSEMENA M, Thekkumkattil A, Linares Valderrama MI, Kuker RA, et al
    American Thyroid Association Sonographic Risk and Afirma Gene Expression Classifier Alone and in Combination for the Diagnosis of Thyroid Nodules with Bethesda Category III Cytology.
    Thyroid. 2020 May 2. doi: 10.1089/thy.2019.0673.
    PubMed     Abstract available


    April 2020
  188. FAZELI SR, Zehr B, Amraei R, Toraldo G, et al
    ThyroSeq v2 Testing: Impact on Cytologic Diagnosis, Management, and Cost of Care in Patients with Thyroid Nodule.
    Thyroid. 2020 Apr 29. doi: 10.1089/thy.2019.0191.
    PubMed     Abstract available


  189. CHEN D, Haymart MR
    Disparities research in thyroid cancer: challenges and strategies for improvement.
    Thyroid. 2020 Apr 28. doi: 10.1089/thy.2020.0166.
    PubMed     Abstract available


  190. LEE ZJO, Eslick GD, Edirimanne S
    Investigating anti-thyroglobulin antibody as a prognostic marker for differentiated thyroid cancer: A Meta-Analysis and Systematic Review.
    Thyroid. 2020 Apr 28. doi: 10.1089/thy.2019.0368.
    PubMed     Abstract available


  191. JUNG CK, Jung SH, Jeon S, Jeong YM, et al
    Risk stratification using a novel genetic classifier including <i>PLEKHS1</i> promoter mutations for differentiated thyroid cancer with distant metastasis.
    Thyroid. 2020 Apr 23. doi: 10.1089/thy.2019.0459.
    PubMed     Abstract available


  192. KOTWAL A, Gustafson M, Bornschlegl S, Kottschade L, et al
    Immune checkpoint inhibitor-induced thyroiditis is associated with increased intrathyroidal T lymphocyte subpopulations.
    Thyroid. 2020 Apr 23. doi: 10.1089/thy.2020.0075.
    PubMed     Abstract available


  193. ROTH EM, Lubitz CC, Swan JS, James BC, et al
    Patient-reported quality of life outcome measures in the thyroid cancer population.
    Thyroid. 2020 Apr 15. doi: 10.1089/thy.2020.0038.
    PubMed     Abstract available


  194. STEPHENSON A, Eszlinger M, Stewardson P, McIntyre JB, et al
    Sensitive sequencing analysis suggests TSHR and GNAS as sole driver mutations in hot thyroid nodules.
    Thyroid. 2020 Apr 13. doi: 10.1089/thy.2019.0648.
    PubMed     Abstract available


  195. MUIR C, Menzies AM, J Clifton-Bligh R, Tsang VHM, et al
    Thyroid toxicity following immune checkpoint inhibitor treatment in advanced cancer.
    Thyroid. 2020 Apr 7. doi: 10.1089/thy.2020.0032.
    PubMed     Abstract available


  196. CHEN T, Gilfix B, Rivera JA, Sadeghi N, et al
    The Role of the ThyroSeq v3 Molecular Test in the Surgical Management of Thyroid Nodules in the Canadian Public Healthcare Setting.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0539.
    PubMed     Abstract available


  197. POZDEYEV N, Erickson T, Zhang L, Ellison K, et al
    Comprehensive Immune Profiling of Medullary Thyroid Cancer.
    Thyroid. 2020 Apr 3. doi: 10.1089/thy.2019.0604.
    PubMed     Abstract available


    March 2020
  198. FAUSTINO LC, Li CW, Stefan M, Kim K, et al
    A novel mouse model of autoimmune thyroiditis induced by immunization with adenovirus containing full-length thyroglobulin cDNA: Implications to genetic studies of thyroid autoimmunity.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0711.
    PubMed     Abstract available


  199. HONG MJ, Na DG, Lee H
    Diagnostic efficacy and safety of core needle biopsy as a first-line diagnostic method for thyroid nodules: a prospective cohort study.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0444.
    PubMed     Abstract available


  200. ENDO M, Nabhan F, Angell TE, Harrell M, et al
    Use of Molecular Diagnostic Tests in Thyroid Nodules with Hurthle Cell-Dominant Cytology.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2020.0021.
    PubMed     Abstract available


  201. MCKELVEY BA, Gilpatrick T, Wang Y, Timp W, et al
    Characterization of Allele-Specific Regulation of Telomerase Reverse Transcriptase in Promoter Mutant Thyroid Cancer Cell Lines.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2020.0055.
    PubMed     Abstract available


  202. RAHMAN S, Pandeya N, Neale RE, McLeod DSA, et al
    Obesity is associated with BRAF V600E-mutated thyroid cancer.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0654.
    PubMed     Abstract available


  203. YIN N, Sherman SI, Pak Y, Litofsky D, et al
    The De novo Detection of Anti-thyroglobulin Antibodies and Differentiated Thyroid Cancer Recurrence.
    Thyroid. 2020 Mar 31. doi: 10.1089/thy.2019.0791.
    PubMed     Abstract available


  204. CABANILLAS M, Dadu R, Iyer PC, Wanland KB, et al
    Acquired secondary RAS mutation in BRAFV600E mutated thyroid cancer patients treated with BRAF inhibitors.
    Thyroid. 2020 Mar 26. doi: 10.1089/thy.2019.0514.
    PubMed     Abstract available


  205. SUKPANICH R, Sanglestsawai S, Seib CD, Gosnell JE, et al
    The influence of cosmetic concerns on patient preferences for approaches to thyroid lobectomy: A discrete choice experiment.
    Thyroid. 2020 Mar 24. doi: 10.1089/thy.2019.0821.
    PubMed     Abstract available


  206. PEPLAU E, De Rose F, Reder S, Mittelhaeuser M, et al
    Development of a chimeric Fab directed against human galectin-3 and validation as an immune-PET tracer for the sensitive in vivo imaging of thyroid cancer.
    Thyroid. 2020 Mar 21. doi: 10.1089/thy.2019.0670.
    PubMed     Abstract available


  207. PAPALEONTIOU M, Evron J, Esfandiari N, Reyes-Gastelum D, et al
    Patient Report of Recurrent and Persistent Thyroid Cancer.
    Thyroid. 2020 Mar 18. doi: 10.1089/thy.2019.0652.
    PubMed     Abstract available


  208. PAPALEONTIOU M, Haymart MR
    Too much of a good thing? A cautionary tale of thyroid cancer overdiagnosis and overtreatment.
    Thyroid. 2020 Mar 11. doi: 10.1089/thy.2020.0185.
    PubMed     Abstract available


  209. LI H, Wang Z, Liu JS, Zou BS, et al
    Association between breast and thyroid lesions: a cross-sectional study based on ultrasonography screening in China.
    Thyroid. 2020 Mar 8. doi: 10.1089/thy.2019.0184.
    PubMed     Abstract available


  210. AHMADI S, Gonzalez Sepulveda JM, Talbott M, Reed S, et al
    Patient preferences around extent of surgery in low-risk thyroid cancer: A discrete-choice experiment.
    Thyroid. 2020 Mar 6. doi: 10.1089/thy.2019.0590.
    PubMed     Abstract available


  211. SAWKA AM, Ghai S, Yoannidis T, Rotstein L, et al
    A prospective mixed-methods study of decision-making on surgery or active surveillance for low risk papillary thyroid cancer.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0592.
    PubMed     Abstract available


  212. YEH T, Yeung M, Sherman EJ, Tuttle RM MD, et al
    Structural doubling time predicts overall survival in patients with medullary thyroid cancer in patients with rapidly progressive metastatic medullary thyroid cancer treated with molecular targeted therapies.
    Thyroid. 2020 Mar 4. doi: 10.1089/thy.2019.0579.
    PubMed     Abstract available


  213. KIM M, Kim SJ, Xu Z, Ha SY, et al
    <i>BRAF<sup>V600E</i></sup> Transduction of SV40-immortalized Normal Human Thyroid Cell Line Induces Dedifferentiated Thyroid Carcinogenesis in a Mouse Xenograft Model.
    Thyroid. 2020 Mar 2. doi: 10.1089/thy.2019.0301.
    PubMed     Abstract available


    February 2020
  214. YIP L
    Thoughtful Utilization of Molecular Testing in Refining Thyroid Nodule Risk Assessment: Don't Throw Out the Baby.
    Thyroid. 2020 Feb 28. doi: 10.1089/thy.2020.0148.
    PubMed     Abstract available


  215. JHIANG SM, Konda B, Sipos JA, Nabhan F, et al
    Prospects for Re-differentiating Agents in the Use of Radioactive Iodine Therapy for Thyroid Cancer.
    Thyroid. 2020 Feb 27. doi: 10.1089/thy.2020.0143.
    PubMed     Abstract available


  216. PEREIRA MM, Williams VL, Hallanger-Johnson JE, Valderrabano P, et al
    Thyroid Cancer Incidence Trends in the United States: Association with Changes in Professional Guidelines' recommendations.
    Thyroid. 2020 Feb 26. doi: 10.1089/thy.2019.0415.
    PubMed     Abstract available


  217. NIES M, Cantineau AEP, Arts EGJM, van den Berg MH, et al
    Long-Term Effects of Radioiodine Treatment on Female Fertility in Survivors of Childhood Differentiated Thyroid Carcinoma.
    Thyroid. 2020 Feb 20. doi: 10.1089/thy.2019.0560.
    PubMed     Abstract available


  218. CHEN JY, Ji QH, Bai C, Zheng X, et al
    Surufatinib in Chinese patients with locally advanced or metastatic differentiated thyroid cancer and medullary thyroid cancer: A multicenter, open-label, Phase II trial.
    Thyroid. 2020 Feb 19. doi: 10.1089/thy.2019.0453.
    PubMed     Abstract available


  219. NIEDERLE MB, Scheuba C, Riss P, Selberherr A, et al
    Early diagnosis of medullary thyroid cancer: Are calcitonin stimulation tests still indicated in the era of highly sensitive calcitonin immunoassays?
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0785.
    PubMed     Abstract available


  220. CESAREO R, Pacella CM, Pasqualini V, Campagna G, et al
    Laser Ablation versus Radiofrequency Ablation for benign non-functioning thyroid nodules: Six-month results of a randomised, parallel, open-label, trial (LARA trial).
    Thyroid. 2020 Feb 14. doi: 10.1089/thy.2019.0660.
    PubMed     Abstract available


  221. ZHAO Y, Yu T, Chen L, Xie D, et al
    A Germline <i>CHEK2</i> Mutation in a Family with Papillary Thyroid Cancer.
    Thyroid. 2020 Feb 11. doi: 10.1089/thy.2019.0774.
    PubMed     Abstract available


  222. PEREZ-SOTO RH, Velazquez-Fernandez D, Arellano-Gutierrez G, Chapa Ibarguengoitia M, et al
    Preoperative and postoperative risk stratification of thyroid papillary microcarcinoma. A comparative study between Kuma criteria and 2015 ATA guidelines risk stratification.
    Thyroid. 2020 Feb 7. doi: 10.1089/thy.2019.0698.
    PubMed     Abstract available


  223. REN Y, Kyriazidis N, Faquin WC, Soylu S, et al
    The presence of Hurthle cells does not increase the risk of malignancy in most Bethesda categories in thyroid fine-needle aspirates.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0190.
    PubMed     Abstract available


  224. THOMAS J, Haertling T
    AIBx, artificial intelligence model to risk stratify thyroid nodules.
    Thyroid. 2020 Feb 4. doi: 10.1089/thy.2019.0752.
    PubMed     Abstract available


    January 2020
  225. GUAN H, Toraldo G, Cerda SR, Godley FA, et al
    Utilities of RAS mutations in pre-operative fine needle biopsies for decision-making for thyroid nodule management: results from a single-center prospective cohort.
    Thyroid. 2020 Jan 29. doi: 10.1089/thy.2019.0116.
    PubMed     Abstract available


  226. SARACYN M, Lubas A, Bober B, Kowalski L, et al
    <b>Recombinant human thyrotropin worsens renal cortical perfusion and renal function in patients after total thyroidectomy due to differentiated thyroid cancer</b>.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0372.
    PubMed     Abstract available


  227. LI M, Brito JP, Vaccarella S
    Long term declines of thyroid cancer mortality: an international age-period-cohort analysis.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0684.
    PubMed     Abstract available


  228. LIU L, Zhang X, Tian T, Huang R, et al
    Prognostic value of pre-ablation stimulated thyroglobulin in children and adolescents with differentiated thyroid cancer.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0585.
    PubMed     Abstract available


  229. GONZALEZ-VELAZQUEZ CD, O'Malley QF, Yue LE, Urken ML, et al
    Letter to the editor: Treatment decisions in thyroid microcarcinomas: Identifying gaps in knowledge to empower our patients.
    Thyroid. 2020 Jan 22. doi: 10.1089/thy.2019.0451.
    PubMed     Abstract available


  230. PERSICHETTI A, Di Stasio E, Coccaro C, Graziano FM, et al
    Inter- and Intra-Observer Agreement in the Assessment of Thyroid Nodule Ultrasound Features and Classification systems: A Blinded Multicenter Study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0360.
    PubMed     Abstract available


  231. LEE YK, Hwangbo Y, Lee S, Lee DE, et al
    Aspirin use is not associated with lower thyroid cancer risk: A nationwide nested case-control study.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0641.
    PubMed     Abstract available


  232. SANABRIA A
    Experience with active surveillance of thyroid microcarcinomalow-risk carcinoma in a developing country.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0522.
    PubMed     Abstract available


  233. JACK GA, Sternberg SB, Aronson MD, Mukamal KJ, et al
    <b>Non-Diagnostic Fine-Needle Aspiration Biopsy of Thyroid Nodules: Outcomes and Determinants</b>.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0140.
    PubMed     Abstract available


  234. PAPARODIS R, Karvounis E, Bantouna D, Chourpiliadis C, et al
    Incidentally discovered papillary thyroid microcarcinomas are more frequently found in patients with chronic lymphocytic thyroiditis than with multinodular goiter or Graves disease.
    Thyroid. 2020 Jan 17. doi: 10.1089/thy.2019.0347.
    PubMed     Abstract available


  235. MORENO I, Hirsch D, Duskin-Bitan H, Diker-Cohen T, et al
    Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients- Is rhTSH Stimulation Required?
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0431.
    PubMed     Abstract available


  236. HE H, Li W, Comiskey DF Jr, Liyanarachchi S, et al
    A truncating germline mutation of TINF2 in individuals with thyroid cancer or melanoma results in longer telomeres.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0156.
    PubMed     Abstract available


  237. VAN VELSEN EFS, Visser WE, van den Berg S, Kam BLR, et al
    Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2019.0504.
    PubMed     Abstract available


  238. OH JM, Baek SH, Gangadaran P, Hong CM, et al
    A novel tyrosine kinase inhibitor can augment radioactive iodine uptake through endogenous sodium/iodide symporter (NIS) expression in anaplastic thyroid cancer.
    Thyroid. 2020 Jan 13. doi: 10.1089/thy.2018.0626.
    PubMed     Abstract available


  239. ZAFEREO M, McIver B, Vargas S, Dominguez Ruiz-Tagle JM, et al
    A THYROID GENETIC CLASSIFIER CORRECTLY PREDICTS BENIGN NODULES WITH INDETERMINATE CYTOLOGY: TWO-INDEPENDENT MULTICENTER, PROSPECTIVE VALIDATION TRIALS.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0490.
    PubMed     Abstract available


  240. ZHANG M, Tufano RP, Russell J, Zhang Y, et al
    Ultrasound-guided radiofrequency ablation versus surgery for low risk papillary thyroid micro-carcinoma: results of over 5 years follow-up.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0147.
    PubMed     Abstract available


  241. SUGINO K, Nagahama M, Kitagawa W, Ohkuwa K, et al
    Risk stratification of pediatric patients with differentiated thyroid cancer: Is total thyroidectomy necessary for patients at any risk? .
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0231.
    PubMed     Abstract available


  242. JASIM S, Baranski T, Teefey S, Middleton WD, et al
    Investigating the effect of thyroid nodule location on the risk of thyroid cancer.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0478.
    PubMed     Abstract available


  243. YOSHIDA Y, Horiuchi K, Okamoto T
    Patients' view on the management of papillary thyroid microcarcinoma: active surveillance or surgery.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0420.
    PubMed     Abstract available


  244. JENSEN CB, Saucke MC, Francis DO, Voils CI, et al
    From Overdiagnosis to Overtreatment of Low-risk Thyroid Cancer: A Thematic Analysis of Attitudes and Beliefs of Endocrinologists, Surgeons, and Patients.
    Thyroid. 2020 Jan 7. doi: 10.1089/thy.2019.0587.
    PubMed     Abstract available


    December 2019
  245. YUAN Q, Wu G, Hou J, Liao X, et al
    Correlation between electrophysiological changes and outcomes of vocal cord function in 1764 recurrent laryngeal nerves with visual integrity during thyroidectomy.
    Thyroid. 2019 Dec 27. doi: 10.1089/thy.2019.0361.
    PubMed     Abstract available


  246. PARIHAR AS, Mittal BR, Kumar R, Shukla J, et al
    68Ga-DOTA-RGD2 PET/CT in radioiodine (131I) refractory thyroid cancer - Prospective comparison of diagnostic accuracy with 18F-FDG PET/CT and evaluation towards potential theranostics.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0450.
    PubMed     Abstract available


  247. JUN JK, Hwang SY, Hong S, Suh M, et al
    Association of screening by thyroid ultrasonography with mortality in thyroid cancer: a case-control study using data from two national surveys.
    Thyroid. 2019 Dec 23. doi: 10.1089/thy.2019.0460.
    PubMed     Abstract available


  248. MASAKI C, Sugino K, Saito N, Akaishi J, et al
    Efficacy and limitations of lenvatinib therapy for radioiodine-refractory differentiated thyroid cancer: real-world experiences.
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0221.
    PubMed     Abstract available


  249. NERVO A, Ragni A, Gallo M, Ferraris A, et al
    SYMPTOMATIC BILIARY DISORDERS DURING LENVATINIB TREATMENT FOR THYROID CANCER: AN UNDERESTIMATED PROBLEM?
    Thyroid. 2019 Dec 19. doi: 10.1089/thy.2019.0355.
    PubMed     Abstract available


  250. CRAIG SJ, Bysice A, Nakoneshny SC, Pasieka JL, et al
    THE IDENTIFICATION OF INTRA-OPERATIVE RISK FACTORS CAN REDUCE, BUT NOT EXCLUDE, THE NEED FOR COMPLETION THYROIDECTOMY IN LOW-RISK PAPILLARY THYROID CANCER PATIENTS.
    Thyroid. 2019 Dec 6. doi: 10.1089/thy.2019.0274.
    PubMed     Abstract available


  251. CHOI Y, Jung SL
    Efficacy and safety of thermal ablation techniques for the treatment of primary papillary thyroid microcarcinoma: a systematic review and meta-analysis.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0707.
    PubMed     Abstract available


  252. PARK JL, Jeon S, Seo E, Bae DH, et al
    Comprehensive DNA methylation profiling identifies novel diagnostic biomarkers for thyroid cancer.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0011.
    PubMed     Abstract available


  253. VYDRO L, Kitahara CM, Lubin JH, Schneider AB, et al
    Among Individuals Irradiated for Benign Conditions in Childhood, Developing Thyroid Cancer Does Not Affect All-cause Survival.
    Thyroid. 2019 Dec 4. doi: 10.1089/thy.2019.0439.
    PubMed     Abstract available


    October 2019
  254. MASOODI T, Siraj AK, Siraj S, Azam S, et al
    Whole Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.
    Thyroid. 2019 Oct 31. doi: 10.1089/thy.2019.0052.
    PubMed     Abstract available


  255. FUZIWARA CS, Saito KC, Kimura ET
    Thyroid follicular cell loss of differentiation induced by miRNA miR-17-92 cluster is attenuated by CRISPR/Cas9n gene silencing in anaplastic thyroid cancer.
    Thyroid. 2019 Oct 3. doi: 10.1089/thy.2018.0601.
    PubMed     Abstract available


  256. JAIN NK, Mostoufi-Moab S, Hawkes CP, Nelson ND, et al
    Extrathyroidal Extension is an Important Predictor of Regional Lymph Node Metastasis in Pediatric Differentiated Thyroid Cancer.
    Thyroid. 2019 Oct 1. doi: 10.1089/thy.2019.0229.
    PubMed     Abstract available


    September 2019
  257. IANNI F, Pascucci D, Paragliola RM, Rota CA, et al
    Follow-up or surgery for indeterminate thyroid nodules: could the CUT score application be a support for decision making in the preoperative assessment?
    Thyroid. 2019 Sep 25. doi: 10.1089/thy.2018.0649.
    PubMed     Abstract available


  258. ZAHEDI A, Bondaz L, Rajaraman M, Leslie WD, et al
    Risk for Thyroid Cancer Recurrence Is Higher In Men Than In Women Independent of Disease Stage At Presentation.
    Thyroid. 2019 Sep 16. doi: 10.1089/thy.2018.0775.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: